ZA933178B - Pharmaceutical compositions of 5ht,-like receptor agonists for rectal administration - Google Patents

Pharmaceutical compositions of 5ht,-like receptor agonists for rectal administration

Info

Publication number
ZA933178B
ZA933178B ZA933178A ZA933178A ZA933178B ZA 933178 B ZA933178 B ZA 933178B ZA 933178 A ZA933178 A ZA 933178A ZA 933178 A ZA933178 A ZA 933178A ZA 933178 B ZA933178 B ZA 933178B
Authority
ZA
South Africa
Prior art keywords
pct
rectal administration
pharmaceutical compositions
receptor agonists
sec
Prior art date
Application number
ZA933178A
Other languages
English (en)
Inventor
Nadine Merlet
Isabelle Richard
Isabelle Thielemans
Original Assignee
Glaxo Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa
Publication of ZA933178B publication Critical patent/ZA933178B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
ZA933178A 1992-05-07 1993-05-06 Pharmaceutical compositions of 5ht,-like receptor agonists for rectal administration ZA933178B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929209882A GB9209882D0 (en) 1992-05-07 1992-05-07 Compositions

Publications (1)

Publication Number Publication Date
ZA933178B true ZA933178B (en) 1994-01-10

Family

ID=10715158

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA933178A ZA933178B (en) 1992-05-07 1993-05-06 Pharmaceutical compositions of 5ht,-like receptor agonists for rectal administration

Country Status (33)

Country Link
US (1) US5705506A (OSRAM)
EP (1) EP0639072B1 (OSRAM)
JP (1) JPH07506570A (OSRAM)
KR (1) KR100253111B1 (OSRAM)
AT (1) ATE163850T1 (OSRAM)
AU (1) AU670083B2 (OSRAM)
BE (1) BE1007024A5 (OSRAM)
BG (1) BG62120B1 (OSRAM)
BR (1) BR1100108A (OSRAM)
CA (1) CA2135179C (OSRAM)
CH (1) CH685920A5 (OSRAM)
CY (1) CY2039B1 (OSRAM)
CZ (1) CZ283512B6 (OSRAM)
DE (1) DE69317418T2 (OSRAM)
ES (1) ES2113533T3 (OSRAM)
FR (1) FR2690847B1 (OSRAM)
GB (2) GB9209882D0 (OSRAM)
GR (1) GR3026584T3 (OSRAM)
HK (1) HK95697A (OSRAM)
HU (2) HU227338B1 (OSRAM)
IE (1) IE75203B1 (OSRAM)
IL (1) IL105468A (OSRAM)
IT (1) IT1261471B (OSRAM)
NO (1) NO306700B1 (OSRAM)
NZ (1) NZ252132A (OSRAM)
OA (1) OA10109A (OSRAM)
RO (1) RO112993B1 (OSRAM)
RU (1) RU2118527C1 (OSRAM)
SG (1) SG46649A1 (OSRAM)
TW (1) TW231970B (OSRAM)
UA (1) UA37206C2 (OSRAM)
WO (1) WO1993021916A1 (OSRAM)
ZA (1) ZA933178B (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2434297A (en) * 1996-05-23 1997-12-09 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
KR100440553B1 (ko) * 1998-03-26 2004-07-15 후지사와 야꾸힝 고교 가부시키가이샤 서방성 제제
WO2000051624A2 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Methods and compositions useful in inhibiting apoptosis
AR056690A1 (es) * 2005-10-14 2007-10-17 Athersys Inc Derivados de indol como inhibidores de indol como inhibidores del receptor 3 de histamina para el tartamiento de trastornos del sueno y cognitivos obesidad y otros trastornos de snc
SI2124556T1 (sl) 2006-10-09 2015-01-30 Charleston Laboratories, Inc. Farmacevtske sestave
CA2749273C (en) 2008-01-09 2018-09-04 Charleston Laboratories, Inc. Pharmaceutical oral dosage form comprising a triptan and an antiemetic
EP3311667A1 (en) 2009-07-08 2018-04-25 Charleston Laboratories, Inc. Pharmaceutical compositions
EP2627328B1 (en) 2010-10-15 2016-09-14 Contera Pharma APS Combinations of serotonin receptor agonists for treatment of movement disorders
HUE037732T2 (hu) 2012-04-18 2018-09-28 Contera Pharma Aps A mozgászavarok fejlett kezelésére alkalmas, szájon át szedhetõ gyógyszerészeti készítmény
JP2019507181A (ja) 2016-03-04 2019-03-14 チャールストン ラボラトリーズ，インコーポレイテッド 医薬組成物
EP3481385B1 (en) 2016-07-11 2025-09-03 Contera Pharma A/S Pulsatile drug delivery system for treating morning akinesia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
NZ197998A (en) * 1980-08-12 1985-08-16 Glaxo Group Ltd 5-amino(methyl)-1h-indol-3-ylalkaneamines
IT1170387B (it) * 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
HU196752B (en) * 1983-12-06 1989-01-30 Glaxo Group Ltd Process for production of medical compositions containing indole-derivatives and these compounds
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
US4785016A (en) * 1984-12-04 1988-11-15 Glaxo Group Limited Indole derivatives
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
DE3678805D1 (de) * 1985-11-08 1991-05-23 Glaxo Group Ltd Indolderivate.
ES2058292T3 (es) * 1987-08-13 1994-11-01 Glaxo Group Ltd Derivados de indol.
ATE156823T1 (de) * 1990-06-07 1997-08-15 Zeneca Ltd Therapeutische heterocyclische verbindungen

Also Published As

Publication number Publication date
GR3026584T3 (en) 1998-07-31
CH685920A5 (fr) 1995-11-15
ATE163850T1 (de) 1998-03-15
EP0639072B1 (en) 1998-03-11
GB9309209D0 (en) 1993-06-16
SG46649A1 (en) 1998-02-20
CA2135179A1 (en) 1993-11-11
GB2266665B (en) 1996-05-22
NO944214L (no) 1994-11-07
CZ283512B6 (cs) 1998-04-15
GB2266665A (en) 1993-11-10
WO1993021916A1 (en) 1993-11-11
NZ252132A (en) 1996-09-25
IT1261471B (it) 1996-05-23
OA10109A (en) 1996-12-18
IL105468A (en) 1998-09-24
NO306700B1 (no) 1999-12-13
CA2135179C (en) 2000-12-05
BE1007024A5 (fr) 1995-02-21
FR2690847B1 (fr) 1995-06-09
HUT71418A (en) 1995-11-28
ITRM930286A1 (it) 1994-11-06
HK95697A (en) 1997-08-08
HU211638A9 (en) 1995-12-28
DE69317418D1 (de) 1998-04-16
BG99167A (bg) 1995-06-30
CY2039B1 (en) 1998-04-30
IE930339A1 (en) 1993-11-17
BR1100108A (pt) 1999-12-07
UA37206C2 (uk) 2001-05-15
KR100253111B1 (en) 2000-07-01
NO944214D0 (no) 1994-11-04
CZ272394A3 (en) 1995-10-18
RU2118527C1 (ru) 1998-09-10
IE75203B1 (en) 1997-08-27
DE69317418T2 (de) 1998-07-30
IL105468A0 (en) 1993-08-18
AU4064093A (en) 1993-11-29
AU670083B2 (en) 1996-07-04
TW231970B (OSRAM) 1994-10-11
ITRM930286A0 (it) 1993-05-06
FR2690847A1 (fr) 1993-11-12
JPH07506570A (ja) 1995-07-20
BG62120B1 (bg) 1999-03-31
HU227338B1 (en) 2011-04-28
GB9209882D0 (en) 1992-06-24
ES2113533T3 (es) 1998-05-01
EP0639072A1 (en) 1995-02-22
RO112993B1 (ro) 1998-03-30
US5705506A (en) 1998-01-06

Similar Documents

Publication Publication Date Title
NZ315740A (en) Oral fast-dissolving compositionsfor dopamine agonists
AP2001002129A0 (en) 5HT1 receptor agonists and metoclopramide for the treatment of migrane.
DE69932173D1 (de) Adenine-derivate
ZA933178B (en) Pharmaceutical compositions of 5ht,-like receptor agonists for rectal administration
MY117274A (en) Polycyclic amine compounds and their enantiomers,their method of preparation and pharmaceutical compositions in which they are present.
MX9702865A (es) Agentes estrogenicos.
MY136249A (en) Phenylethanolamine compounds as anti-obesity agents
ZA971279B (en) Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhinitors
EP0903349A3 (en) CCR-3 receptor antagonists
ES2160949T3 (es) Derivados de fenilen-sulfonamida sustituidos en meta.
IL114598A0 (en) Triazole compounds their preparation and pharmaceutical compositions containing them
MXPA03000548A (es) Combinacion novedosa de agonista (5-ht2) y antagonistas (5-ht6) de serotonina como formulacion farmaceutica.
IL114600A0 (en) Thiazole and thiadiazole compounds their preparation and pharmaceutical composition containing them
WO2000000198A8 (en) Piperidine derivatives having effects on serotonin related systems
EP0485431A4 (en) Partial agonists of the strychnine insensitive glycine modulatory site of the n-methyl-d-aspartate receptor complex as neuropsychopharmacological agents
EP1064966A3 (en) Combination of an 5HT1 receptor antagonist, caffeine and a cyclooxygenase-2 inhibitor for the treatment of migraine
GR3036195T3 (en) Novel compounds
EP1051994A3 (en) 5HT1 receptor agonists and a COX-2 inhibitor for the treatment of migraine
ES2141671A1 (es) Compuesto pirimidinico activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.